Goldman Sachs Group Inc Xencor Inc Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Xencor Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 367,137 shares of XNCR stock, worth $9.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
367,137
Previous 464,812 21.01%
Holding current value
$9.77 Million
Previous $8.8 Million 16.08%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$15.7 - $21.65 $1.53 Million - $2.11 Million
-97,675 Reduced 21.01%
367,137 $7.38 Million
Q2 2024

Aug 13, 2024
BUY
$18.21 - $24.5 $2.3 Million - $3.09 Million
126,304 Added 37.31%
464,812 $8.8 Million
Q1 2024

May 15, 2024
SELL
$18.65 - $26.52 $1.85 Million - $2.64 Million
-99,392 Reduced 22.7%
338,508 $7.49 Million
Q4 2023

Feb 13, 2024
BUY
$16.53 - $21.42 $4.21 Million - $5.45 Million
254,537 Added 138.82%
437,900 $9.3 Million
Q3 2023

May 14, 2024
SELL
$20.08 - $25.39 $5.11 Million - $6.46 Million
-254,537 Reduced 58.13%
183,363 $3.69 Million
Q3 2023

Nov 14, 2023
SELL
$20.08 - $25.39 $7.71 Million - $9.75 Million
-383,982 Reduced 67.68%
183,363 $3.69 Million
Q2 2023

May 14, 2024
SELL
$24.77 - $29.9 $1.57 Million - $1.9 Million
-63,384 Reduced 10.05%
567,345 $14.2 Million
Q2 2023

Aug 14, 2023
SELL
$24.77 - $29.9 $1.57 Million - $1.9 Million
-63,384 Reduced 10.05%
567,345 $14.2 Million
Q1 2023

May 14, 2024
SELL
$25.95 - $36.95 $2.03 Million - $2.88 Million
-78,058 Reduced 11.01%
630,729 $17.6 Million
Q1 2023

May 11, 2023
SELL
$25.95 - $36.95 $2.03 Million - $2.88 Million
-78,058 Reduced 11.01%
630,729 $17.6 Million
Q4 2022

May 14, 2024
BUY
$24.79 - $30.86 $1.46 Million - $1.81 Million
58,717 Added 9.03%
708,787 $18.5 Million
Q4 2022

Feb 13, 2023
BUY
$24.79 - $30.86 $1.46 Million - $1.81 Million
58,717 Added 9.03%
708,787 $18.5 Million
Q3 2022

May 14, 2024
BUY
$24.62 - $32.44 $3.16 Million - $4.16 Million
128,289 Added 24.59%
650,070 $16.9 Million
Q3 2022

Nov 10, 2022
BUY
$24.62 - $32.44 $3.16 Million - $4.16 Million
128,289 Added 24.59%
650,070 $16.9 Million
Q2 2022

May 14, 2024
BUY
$19.74 - $29.01 $1.66 Million - $2.43 Million
83,881 Added 19.16%
521,781 $14.3 Million
Q2 2022

Aug 15, 2022
BUY
$19.74 - $29.01 $8 Million - $11.8 Million
405,458 Added 348.56%
521,781 $14.3 Million
Q1 2022

May 16, 2022
BUY
$26.68 - $41.63 $393,369 - $613,792
14,744 Added 14.51%
116,323 $3.1 Million
Q4 2021

Feb 14, 2022
BUY
$33.67 - $43.44 $1.39 Million - $1.8 Million
41,413 Added 68.83%
101,579 $4.08 Million
Q3 2021

Nov 10, 2021
BUY
$30.65 - $35.68 $1.84 Million - $2.15 Million
60,166 New
60,166 $1.97 Million

Others Institutions Holding XNCR

# of Institutions
216
Shares Held
71.8M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.59B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email